Pasithea Therapeutics Corp. (KTTA)
0.49
0.00 (0.00%)
USD |
NASDAQ |
Oct 22, 09:52
Pasithea Therapeutics Price to Book Value : 0.3285 for Oct. 22, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 21, 2026 | 0.327 |
| October 20, 2026 | 0.2749 |
| October 19, 2026 | 0.2764 |
| October 16, 2026 | 0.2816 |
| October 15, 2026 | 0.2749 |
| October 14, 2026 | 0.2745 |
| October 13, 2026 | 0.2841 |
| October 12, 2026 | 0.30 |
| October 09, 2026 | 0.3134 |
| October 08, 2026 | 0.2956 |
| October 07, 2026 | 0.2973 |
| October 06, 2026 | 0.2997 |
| October 05, 2026 | 0.305 |
| October 02, 2026 | 0.3191 |
| October 01, 2026 | 0.3279 |
| September 30, 2026 | 0.3305 |
| September 29, 2026 | 0.3285 |
| September 28, 2026 | 0.3218 |
| September 25, 2026 | 0.3347 |
| September 24, 2026 | 0.3444 |
| September 23, 2026 | 0.3437 |
| September 22, 2026 | 0.3447 |
| September 21, 2026 | 0.3422 |
| September 18, 2026 | 0.3511 |
| September 17, 2026 | 0.3397 |
| Date | Value |
|---|---|
| September 16, 2026 | 0.3285 |
| September 15, 2026 | 0.3352 |
| September 14, 2026 | 0.3419 |
| September 11, 2026 | 0.3553 |
| September 10, 2026 | 0.362 |
| September 09, 2026 | 0.3819 |
| September 08, 2026 | 0.4016 |
| September 04, 2026 | 0.3889 |
| September 03, 2026 | 0.3891 |
| September 02, 2026 | 0.3891 |
| September 01, 2026 | 0.3775 |
| August 31, 2026 | 0.3848 |
| August 28, 2026 | 0.3754 |
| August 27, 2026 | 0.3718 |
| August 26, 2026 | 0.3821 |
| August 25, 2026 | 0.3754 |
| August 24, 2026 | 0.3386 |
| August 21, 2026 | 0.3616 |
| August 20, 2026 | 0.3151 |
| August 19, 2026 | 0.3285 |
| August 18, 2026 | 0.3336 |
| August 17, 2026 | 0.3205 |
| August 14, 2026 | 0.3221 |
| August 13, 2026 | 0.3205 |
| August 12, 2026 | 0.3285 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.695 |
| Alnylam Pharmaceuticals, Inc. | 22.45 |
| Anika Therapeutics, Inc. | 1.985 |
| Savara, Inc. | 6.720 |
| Vericel Corp. | 5.672 |
Price to Book Value Related Metrics
| Price | 0.49 |
| Earnings Yield | -322.4% |
| Market Cap | 16.37M |